Web Results

Vaso Active Pharmaceuticals, Inc., Debtors, Jeoffrey L. Burtch ...

www.deb.uscourts.gov/sites/default/files/opinions/judge-christopher-s.sontchi/opinion.8.11.14.pdf

Aug 11, 2014 ... FOR THE DISTRICT OF DELAWARE. In re: ) Chapter 11. ) VASO ACTIVE PHARMACEUTICALS, INC., ). ) Case No. 10-10855 (CSS). Debtors.

Cases | A.B. Data Class Action Administration

www.abdataclassaction.com/cases/

Beverly Enterprises - Arkansas, Inc., et al. and Vera Cooney and Eula Mae Allen, et al., v. Beverly ...... In re Vaso Active Pharmaceuticals Securities Litigation.

A novel angiotensin-converting enzyme-related carboxypeptidase ...

www.ncbi.nlm.nih.gov/pubmed/10969042

Sep 1, 2000 ... (1)Millennium Pharmaceuticals, Inc, Cambridge, MA 02139, USA. ... of key vasoactive peptides suggest an essential role for ACE2 in the local ...

Vaso Active Pharmaceuticals, Inc.: OTCMKTS:VAPHQ quotes ...

www.google.com/finance?cid=688828

Vaso Active Pharmaceuticals, Inc. is a company focused on commercializing, marketing and selling over-the-counter (OTC) pharmaceutical products. Vaso ...

Protected Graft Copolymer Excipient Leads to a Higher ... - PharmaIN

pharmain.com/wp-content/uploads/2014/12/PGC-VIP_Pharm_Res_March_2013.pdf

INTRODUCTION. Vasoactive intestinal peptide (VIP) is a 28 amino-acid neu- ... can be used as a commercial immunotherapeutic drug. Here, two ... PGC was synthesized as described by Castillo et al. (4). Specifi- ... er 20 ml DCM and re- centrifuged. This second .... performed using GraphPad Prism (GraphPad Software Inc.,.

New Value Does Not Need to Remain Unpaid | News & Media

www.bipc.com/New-Value-Does-Not-Need-to-Remain-Unpaid-10-29-2014/

Oct 29, 2014 ... In In re Proliance International, Inc., et al., Judge Sontchi of the ... In re Sierra Concrete Design, Inc. and In re Vaso Active Pharmaceuticals, Inc., ...

Depolarization Increases Vasoactive Intestinal Peptide- and ...

www.jneurosci.org/content/12/10/3717.full.pdf

ganglion (SCG) of the adult rat (Hokfelt et al., 1977; Sasek and. Zigmond, 1989). ... synthesis, depolarization of sympathetic neurons has been re- ported to inhibit the .... by adding 1.5 PM veratridine (ICN Pharmaceuticals Inc., Plainview,. NY).

Adrenomedullin, a New Vasoactive Peptide, Is ... - Hypertension

hyper.ahajournals.org/content/32/4/758.full.pdf

Adrenomedullin, a New Vasoactive Peptide,. Is Increased in ... vasoactive agents. 3. The role of .... a commercial kit (Phoenix Pharmaceuticals Inc) with rabbit poly- ... Di Iorio et al .... and umbilical vein adrenomedullin concentrations may re-.

Interactions of Vasoactive Effects of Adenosine and Potassium Ion ...

circres.ahajournals.org/content/44/2/207.full.pdf

vasoactive agents may interact to relax arterial smooth muscle. These results may have ... lings et aL, 1969; Sybers et al., 1971) and adenosine. (Berne, 1963 ...

Rhythmic Secretion of Prolactin in Rats - Department of Mathematics

www.math.fsu.edu/~bertram/papers/hypothalamus/Xfactor.pdf

dopaminergic inhibition and stimulation by hypothalamic re- ... vasoactive intestinal polypeptide (VIP) from the suprachias- matic nucleus .... ceuticals Inc., Belmont, CA, validated for the use of rat serum) according .... Egli et al. • OT and VIP Involvement in PRL Secretion. Endocrinology, July 2004, 145(7):3386–3394 3387 ...

More Info

George L. Miller v. JNJ Logistics LLC - District of Delaware

www.deb.uscourts.gov

Aug 14, 2014 ... In Re: : : PROLIANCE INTERNATIONAL, INC., et al. : Chapter 7 ...... this ruling in In re Vaso Active Pharmaceuticals, Inc.43 Therein, the.

Vaso Active Pharmaceuticals, Inc. : Lit. Rel. No. 18834 / August 17 ...

www.sec.gov

Aug 17, 2004 ... Litigation Release No. 18834 / August 17, 2004. SEC Files Settled Action Charging Vaso Active Pharmaceuticals, Inc. and its President and ...

Regulation of Dopamine Uptake by Vasoactive Peptides in the Kidney

www.ncbi.nlm.nih.gov

Aug 22, 2016 ... Regulation of Dopamine Uptake by Vasoactive Peptides in the Kidney. N. L. Rukavina Mikusic, N. M. Kouyoumdzian, [...], and M. R. Choi.